Plexiform neurofibromas (PNs) are among the most complex and challenging manifestations of neurofibromatosis type 1 (NF1...
Neurofibromatosis type 1 (NF1) is an autosomal dominant multisystem disorder that presents significant challenges to the...
...NF1). Although usually benign, these lesions can rarely undergo malignant transformation, particularly when associated w...
...NF1).,A multicenter, international, randomized, double-blind, placebo-controlled trial was conducted between July 2009 a...
...NF1 loss and activating RAS mutations lead to RAS-MAPK signaling even in the presence of ALKi. Intriguingly, NF1 loss re...
...NF1 at each concentration (82.32% and 87.18% for ZnO-NF1 and ZnO-NF2, respectively, at 200 mg/mL).
...NF1. Unfortunately, GEM models with Nf1 ablation do not fully recapitulate this process. This led us to develop P0-GGFβ3...
...NF1).,Children with NF1-OPGs involving the optic nerve (extension into the chiasm and tracts permitted) who underwent bo...
Neurofibromatosis type 1 (NF1) is a disorder in which RAS is constitutively activated due to the loss of the Ras-GTPase-...
Half of the patients with Neurofibromatosis type 1 (NF1) develop one or more tumours called plexiform neurofibromas, whi...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
